WebJan 8, 2024 · 4. Financing: Impressive VC, M&A, and IPO activity. Capital flowed into biopharma companies, as shown by record-high VC investment. That trend is expected to continue in 2024, as are strong if not ... WebDatamonitor Healthcare Respiratory ... April 5, 2024. Datamonitor Healthcare CV&Met: Atri... March 31, 2024. Datamonitor Healthcare I&I: Primary... March 31, 2024. …
Biomarker Tracker Data-Driven Health Analytics
Web17 hours ago · A complicated legal fight over the Food and Drug Administration’s approval of the abortion pill mifepristone could stifle innovation in the biopharma industry. If courts affirm U.S. District ... Web2 days ago · CDE’s Pre-NDA Feedback Confirms CBP-201 for Atopic Dermatitis on Track for NDA Submission in China by End of First Quarter 2024. SAN DIEGO and TAICANG, SUZHOU, China, April 11, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage … chs therapy affiliates
Fierce Biotech Homepage Fierce Biotech
WebBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and … WebApr 7, 2024 · Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ... WebApr 10, 2024 · In 2024, despite disruption from the COVID-19 pandemic, more than 100 biotechs priced an IPO, raising nearly $15 billion in total. That momentum recently came to a halt, however. Stock prices of newly public companies plummeted in late 2024 amid a sector-wide downturn that weakened interest in biotech offerings throughout 2024. chs therapy human resources